PANBESY CAPSULE 15 MG

Land: Singapore

Taal: Engels

Bron: HSA (Health Sciences Authority)

Werkstoffen:

PHENTERMINE HCl

Beschikbaar vanaf:

EURODRUG LABORATORIES SINGAPORE PTE. LTD.

ATC-code:

A08AA01

Dosering:

15 mg

farmaceutische vorm:

CAPSULE

Samenstelling:

PHENTERMINE HCl 15 mg

Toedieningsweg:

ORAL

Prescription-type:

Prescription Only

Geproduceerd door:

OSMOPHARM SA

Autorisatie-status:

ACTIVE

Autorisatie datum:

1991-01-07

Productkenmerken

PANBESY
®
APPETITE SUPPERANT
PRESENTATION

Each red and natural colour PANBESY
®
capsule contains 15 mg Phentermine Hydrochloride.

Each
dark
blue
and
natural
colour
PANBESY
®
capsule
contains
30
mg
Phentermine
Hydrochloride.
PANBESY
®
, Phentermine Hydrochloride, is an anorexiant.
The
PANBESY
®
retard
process
induces
a
slow,
gradual
and
continued
release
of Phentermine
Hydrochloride and is therefore well tolerated.
INDICATIONS
For short term use as an adjunct to the treatment of some patients
with moderate to severe obesity.
SIDE EFFECTS
Phentermine Hydrochloride is usually well tolerated in the therapeutic
dosage, though individuals vary
considerably in their reactions. Among the side effects which are
relatively common are dryness of the
mouth, restlessness, headache, insomnia, irritability, dizziness and
tremor. Larger doses may give rise
to
fatigue,
mental
depression,
an
increase
in
blood
pressure,
fever,
cardiovascular
reactions,
disorientation,
hallucinations
and
convulsions.
Palpitation,
tachycardia, overstimulation, euphoria,
dysphoria, rarely psychotic episodes at recommended doses. Unpleasant
taste, diarrhoea, constipation,
other gastrointestinal disturbances, urticaria, impotence, changes in
libido.
OVERDOSAGE
Symptoms: Initially irritability, agitation, disorientation and tremor
may occur, followed by cardiac
arrhythmias, convulsions, hallucinations and coma.
Treatment: The stomach should be emptied by emesis or stomach tube and
washed out with water if
the preparation has been ingested within the last three or four hours.
Diazepam, preferably by mouth
(cautiously by intravenous injection) should be used to control marked
excitement and convulsions.
Provided renal function is adequate, elimination of phentermine may be
assisted by acidification of
the urine by agents such as lysine hydrochloride or arginine
hydrochloride.
RECOMMENDED DOSAGE
Adult: 1-2 capsules of 15 mg a day before breakfast.
Adult: 1 capsule of 30 mg a day before breakfast.
CONTRAINDICATIONS
Epilepsy; hypersensitivity to